Partner Content Partner Content Four weeks until Adaptive Designs in Clinical Trials Confere... Four weeks until SMi’s 11th Annual Conference
Partner Content Partner Content Pfizer’s vice president & Head of Early Clinical Develop... Adaptive Designs in Clinical Trials 2019
Partner Content Partner Content SMi’s Adaptive Design in Clinical Trials - 4 days to go SMi’s Adaptive Design in Clinical Trials
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
